InsidersTradesSigma
Track the LongBio Pharma (Suzhou) Co., Ltd. - B - H Shares share price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Market capitalisation: €8.8bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: LIU Heng. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
隆博生物医药（苏州）有限公司是一家专注于生物治疗药物开发的制药公司。该公司在香港B股上市。